HIGHLIGHTS
- who: Tuukka Helin et al. from the Laboratory Assessment of Unfractionated Heparin (UFH) with Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, POBox, Helsinki, Finland have published the paper: Laboratory Assessment of Unfractionated Heparin (UFH) with Activated Clotting Time (ACT) and Anti-Xa Activity during Peripheral Arterial Angiographic Procedure, in the Journal: Diagnostics 2023, 1489 of /2023/
- what: The authors aimed to test the validity of standard UFH bolus immediately after the bolus and in some cases 1 h into the or a combination thereof (altogether 32 measurements). The authors aimed to assess . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.